Evaluating the toxicity of escalating dose of oral picolinic acid in Sprague-Dawley rats
- 20 September 2021
- journal article
- research article
- Published by Elsevier BV in Toxicology
- Vol. 462, 152960
- https://doi.org/10.1016/j.tox.2021.152960
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council
- University of Sydney
This publication has 18 references indexed in Scilit:
- Medication‐related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosisOral Diseases, 2016
- The Kynurenine Pathway of Tryptophan Degradation is Activated During OsteoblastogenesisThe International Journal of Cell Cloning, 2014
- Downregulation of serum brain specific microRNA is associated with inflammation and infarct volume in acute ischemic strokeJournal of Clinical Neuroscience, 2014
- Interferon (IFN)-γ-mediated inflammation and the kynurenine pathway in relation to bone mineral density: the Hordaland Health StudyClinical and Experimental Immunology, 2014
- Denosumab and atypical femoral fracturesActa Orthopaedica, 2013
- The Kynurenine Pathway in Stem Cell BiologyInternational Journal of Tryptophan Research, 2013
- Kynurenines in the CNS: recent advances and new questionsNature Reviews Drug Discovery, 2012
- Quinolinic acid, the inescapable neurotoxinThe FEBS Journal, 2012
- KYNURENINE PATHWAY METABOLISM IN PATIENTS WITH OSTEOPOROSIS AFTER 2 YEARS OF DRUG TREATMENTClinical and Experimental Pharmacology and Physiology, 2006
- Clinical Pathology Reference Ranges of Laboratory Animals.The Journal of Veterinary Medical Science, 1993